期刊
NANOMATERIALS
卷 5, 期 4, 页码 1853-1879出版社
MDPI
DOI: 10.3390/nano5041853
关键词
nanotheranostics; diagnostics; targeted therapy; cancer; gold nanoparticles; precision medicine; theranostics
类别
资金
- Fundacao para a Ciencia e a Tecnologia (FCT/MEC) [PTDC/BBB-NAN/1812/2012, UCIBIO UID/Multi/04378/2013]
- [SFRH/BD/52211/2013]
- [PD/BD/105734/2014]
- Fundação para a Ciência e a Tecnologia [PTDC/BBB-NAN/1812/2012, PD/BD/105734/2014] Funding Source: FCT
Nanoparticles have been making their way in biomedical applications and personalized medicine, allowing for the coupling of diagnostics and therapeutics into a single nanomaterial-nanotheranostics. Gold nanoparticles, in particular, have unique features that make them excellent nanomaterials for theranostics, enabling the integration of targeting, imaging and therapeutics in a single platform, with proven applicability in the management of heterogeneous diseases, such as cancer. In this review, we focus on gold nanoparticle-based theranostics at the lab bench, through pre-clinical and clinical stages. With few products facing clinical trials, much remains to be done to effectively assess the real benefits of nanotheranostics at the clinical level. Hence, we also discuss the efforts currently being made to translate nanotheranostics into the market, as well as their commercial impact.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据